Clover Health Director & 10% Owner Sells $17.2M in Shares Following RSU Vesting
CLOV sits 23% above its 52-week low of $2.12.
Summary
Vivek Garipalli, a Director and 10% owner of Clover Health, disposed of shares valued at $17.2 million, primarily to cover tax obligations following the vesting of restricted stock units.
Key Events · Ownership and Investor Activity · CLOV
-
Significant Share Disposition
Vivek Garipalli, a Director and 10% owner, disposed of shares totaling $17,285,393.
-
RSU Vesting Trigger
The disposition was primarily driven by the vesting of restricted stock units (RSUs).
-
Tax Withholding
A substantial portion of the shares, valued at $4,288,908, was withheld by the company to cover tax obligations related to the RSU vesting.
-
Net Reduction in Holdings
Post-transaction, Garipalli's direct holdings decreased to 10,247,042 shares.
Analysis · CLOV · Finance
This Form 4 filing indicates a significant disposition of shares by Vivek Garipalli, a Director and 10% owner of Clover Health. While the transactions are primarily related to the vesting of restricted stock units and subsequent mandatory tax withholding, the total value of shares disposed, exceeding $17 million, is notable. Although not a discretionary sale signaling a change in conviction, such a large volume of shares entering the market or being withheld can still impact market dynamics and represents a reduction in direct insider ownership. Investors should monitor future insider activity for any discretionary sales.
At the time of this filing, CLOV was trading at $2.60 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.12 to $4.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.